Literature DB >> 16888218

Comparative study of the effects of PACAP in young, aging, and castrated males in a rat model of Parkinson's disease.

D Reglódi1, A Tamás, I Lengvári, G Toth, L Szalontay, A Lubics.   

Abstract

We have previously shown that PACAP ameliorates the neurological symptoms and reduces the dopaminergic cell loss in young male rats, in a 6-hydroxydopamine (6-OHDA)-induced lesion of the substantia nigra, a model of Parkinson's disease. In the present study, we compared the effects of PACAP in young, aging, and castrated males. Our results show that PACAP significantly reduced the dopaminergic cell loss in young and aging males. In castrated males, 6-OHDA did not induce such a severe cell loss, and it was not altered by PACAP. However, PACAP effectively ameliorated behavioral symptoms in all groups, with a degree of recovery depending on age and endocrine status.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16888218     DOI: 10.1196/annals.1317.072

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  12 in total

1.  PACAP protects against salsolinol-induced toxicity in dopaminergic SH-SY5Y cells: implication for Parkinson's disease.

Authors:  Dwayne Brown; Andrea Tamas; Dora Reglödi; Yousef Tizabi
Journal:  J Mol Neurosci       Date:  2013-04-28       Impact factor: 3.444

2.  Alteration of the PAC1 Receptor Expression in the Basal Ganglia of MPTP-Induced Parkinsonian Macaque Monkeys.

Authors:  M Feher; B Gaszner; A Tamas; A L Gil-Martinez; E Fernandez-Villalba; M T Herrero; D Reglodi
Journal:  Neurotox Res       Date:  2017-12-11       Impact factor: 3.911

3.  Pituitary adenylate cyclase-activating peptide induces long-lasting neuroprotection through the induction of activity-dependent signaling via the cyclic AMP response element-binding protein-regulated transcription co-activator 1.

Authors:  Paul S Baxter; Marc-Andre Martel; Aoife McMahon; Peter C Kind; Giles E Hardingham
Journal:  J Neurochem       Date:  2011-06-17       Impact factor: 5.372

Review 4.  PACAP deficiency as a model of aging.

Authors:  D Reglodi; T Atlasz; E Szabo; A Jungling; A Tamas; T Juhasz; B D Fulop; A Bardosi
Journal:  Geroscience       Date:  2018-10-22       Impact factor: 7.713

5.  PACAP signaling exerts opposing effects on neuroprotection and neuroinflammation during disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.

Authors:  Cornelia Ringer; Luisa-Sybille Büning; Martin K H Schäfer; Lee E Eiden; Eberhard Weihe; Burkhard Schütz
Journal:  Neurobiol Dis       Date:  2013-03-04       Impact factor: 5.996

6.  Crystal structure of the PAC1R extracellular domain unifies a consensus fold for hormone recognition by class B G-protein coupled receptors.

Authors:  Shiva Kumar; Augen Pioszak; Chenghai Zhang; Kunchithapadam Swaminathan; H Eric Xu
Journal:  PLoS One       Date:  2011-05-19       Impact factor: 3.240

7.  Effects of Postnatal Enriched Environment in a Model of Parkinson's Disease in Adult Rats.

Authors:  Adel Jungling; Dora Reglodi; Zsofia Nozomi Karadi; Gabor Horvath; Jozsef Farkas; Balazs Gaszner; Andrea Tamas
Journal:  Int J Mol Sci       Date:  2017-02-14       Impact factor: 5.923

8.  Enriched environment elevates expression of growth associated protein-43 in the substantia nigra of SAMP8 mice.

Authors:  Zhen-Yun Yuan; Jie Yang; Xiao-Wei Ma; Yan-Yong Wang; Ming-Wei Wang
Journal:  Neural Regen Res       Date:  2018-11       Impact factor: 5.135

9.  PACAP Modulates the Autophagy Process in an In Vitro Model of Amyotrophic Lateral Sclerosis.

Authors:  Agata Grazia D'Amico; Grazia Maugeri; Salvatore Saccone; Concetta Federico; Sebastiano Cavallaro; Dora Reglodi; Velia D'Agata
Journal:  Int J Mol Sci       Date:  2020-04-22       Impact factor: 5.923

10.  Alzheimer's Disease Mouse as a Model of Testis Degeneration.

Authors:  Vince Szegeczki; Gabriella Horváth; Helga Perényi; Andrea Tamás; Zsolt Radák; Dóra Ábrahám; Róza Zákány; Dora Reglodi; Tamás Juhász
Journal:  Int J Mol Sci       Date:  2020-08-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.